CytomX Therapeutics (CTMX) Capital Expenditures (2014 - 2025)
CytomX Therapeutics (CTMX) reported Capital Expenditures of $201,000 for Q4 2025, up 151.3% from $80,000 a year earlier.
Powered by 
Analysis
CytomX Therapeutics (CTMX) Capital Expenditures (2014 - 2025) Analysis & Trends
For FY2025, CytomX Therapeutics posted Capital Expenditures of $220,000, down 29.0% from FY2024.
- Capital Expenditures has declined for three consecutive years, with a five-year compound annual growth rate of -37.5% (FY2020 to FY2025).
- By year, Capital Expenditures came in at $310,000 in FY2024 (-63.1%), $840,000 in FY2023 (-51.7%), $1.74 million in FY2022 (+8.1%) and $1.61 million in FY2021 (-30.3%).
- The Q4 2025 figure ranks as the highest quarterly Capital Expenditures since Q4 2023.
- Year over year, Capital Expenditures gained in four of the last seven quarters, with growth averaging 26.0%.
- The high point for year-over-year Capital Expenditures in five years was Q2 2022 (growth of 261.4%); the low point was Q3 2023 (a decline of 97.8%).
- Per Business Quant data, the three quarters before Q4 2025 came in at -$127,000 (Q3 2025), $27,000 (Q2 2025) and $119,000 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 112.20 Mn |
| 10 | CytomX Therapeutics | 586.15 Mn | -371.52 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 201,000.00 |
| Sep 30, 2025 | -127,000.00 |
| Jun 30, 2025 | 27,000.00 |
| Mar 31, 2025 | 119,000.00 |
| Dec 31, 2024 | 80,000.00 |
| Sep 30, 2024 | 19,000.00 |
| Jun 30, 2024 | 96,000.00 |
| Mar 31, 2024 | 115,000.00 |
| Dec 31, 2023 | 266,000.00 |
| Sep 30, 2023 | 9,000.00 |
| Jun 30, 2023 | 517,000.00 |
| Mar 31, 2023 | 48,000.00 |
| Dec 31, 2022 | 182,000.00 |
| Sep 30, 2022 | 410,000.00 |
| Jun 30, 2022 | 412,000.00 |
| Mar 31, 2022 | 736,000.00 |
| Dec 31, 2021 | 245,000.00 |
| Sep 30, 2021 | 268,000.00 |
| Jun 30, 2021 | 114,000.00 |
| Mar 31, 2021 | 982,000.00 |
API Access
CytomX Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=CTMX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "CTMX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=CTMX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();